Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension

American Journal of Cardiology

Volumn 78, Issue 12, 1996, Pages 1385-1389

  Pines, Amos ^a   Fisman, Enrique Z ^b   Shapira, Itzhak ^b   Drory, Yaacov ^b   Weiss, Avraham ^b   Eckstein, Nachman ^b   Levo, Yoram ^b   Averbuch, Mordechai ^b   Motro, Michael ^b   Rotmensch, Heshi H ^b   Ayalon, Daniel ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ECHOGRAPHY; ESTROGEN THERAPY; EXERCISE TEST; FEMALE; HEART; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; POSTMENOPAUSE;

ECHOCARDIOGRAPHY, DOPPLER; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EXERCISE TEST; FEMALE; HEART; HUMANS; HYPERTENSION; MIDDLE AGED; POSTMENOPAUSE; VENTRICULAR FUNCTION, LEFT;

EID: 0030589271     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00646-7     Document Type: Article

References (24)

1. Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cordiol 1995;26:1403-1410.
2. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069-1075.
3. Manolio TA, Furberg CD, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL. Association of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 1993;88[part 1]:2163-2171.
4. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991;325:756-762.
5. Falkebome M, Persson I, Adami HO, Bergstrom R, Eaker E, Lithell H, Mohsen R, Naessen T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992;99:821-828.
6. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995;85:1128-1132.
7. Sullivan JM, Vander Zwaag R, Hughes JP, Maddok V. Kroetz FW. Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease: effect in survival in postmenopausal women. Arch Intern Med 1990;150:2557-2562.
8. Pines A, Fisman EZ, Ayalon D, Drory Y, Averbuch M, Levo Y. Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women. Chest 1992;102:1496-1498.
9. Pines A, Fisman EZ, Averbuch M, Drory Y, Motro M, Levo Y, Weiss A, Rotmensch H, Ayalon D. The long-term effects of transdermal estradiol on left ventricular function and dimensions. Eur Menopause J 1995;2:22-25.
10. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-1687.
11. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89:52-60.
12. Sullivan TR, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96:2482-2488.
13. Fisman EZ, Ben-Ari E, Pines A, Drory Y, Shiner RJ, Motro M, Kellermann JJ. Pronounced reduction of aortic flow velocity and acceleration during heavy isometric exercise in coronary artery disease. Am J Cardiol 1991;68:485-491.
14. Devereux RB, Reichek N. Echocardiographic determinations of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-618.
15. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-2470.
16. Pines A, Fisman EZ, Levo Y, Drory Y, Ben-Ari E, Motro M, Ayalon D. Menopause-induced changes in left ventricular wall thickness. Am J Cardiol 1992;72:240-241.
17. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
18. Sullivan JM, Shala BA, Miller A, Lerner JL, McBrayer JD. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy. Menopause 1995;2:193-199.
19. Prelevic GM, Beljic T. The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy post menopausal women. Maturitas 1994;20:37-44.
20. Harrison MR, Clifton GD, Sublett KL, DeMaria AL. Effect of heart rate on Doppler indexes of systolic function in humans. J Am Coll Cardiol 1989;14:929-935.
21. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
22. Wren BG. Effects of estrogen and management of hypertension in women. In: Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven Press, 1994:283-285.
23. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993;342:133-136.
24. Lim PO, MacFayden RJ, Clarkson PBM, ManDonald TM. Impaired exercise tolerance in hypertensive patients. Ann Intern Med 1996;124:41-55.